Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.

NCT04965649 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelogenous Leukemia
Chronic Leukemia
BCR-ABL Positive Acute Myeloid Leukemia

Interventions

GENETIC: Phenotyping of total and innate CD8+T cells by flow cytometry

Sponsor

Centre Hospitalier Universitaire de Nīmes